Diabetes experts met and determined that some self-monitoring blood glucose (SMBG) systems, despite meeting accuracy standards at the time of U.S. Food and Drug Administration (FDA) clearance, fail to consistently meet accuracy standards once on the market, potentially putting patient health at risk. In a public meeting convened by the Diabetes Technology Society on May 21, 2013, in Arlington, Virginia, leading academic clinicians, clinical chemists, medical device experts, patient advocates and FDA representatives reviewed a growing body of peer-reviewed research demonstrating that the performance of some blood glucose monitors on the market may not be meeting accuracy standards.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/61870-diabetes-technology-society-inaccurate-blood-glucose-monitors-risky
When it comes to bringing the best ingredients together to make memories around America’s tables, Hellmann’s has some experience – 100 years of experience to be exact. Nearly a century ago, regulars in a New York City deli discovered a new condiment that made their club sandwiches even more delicious – just one bite and they were hooked. The secret ingredient was deli owner, Richard Hellmann’s, family recipe for mayonnaise, which would grow to be one of America’s most enduring and iconic food brands – Hellmann’s Mayonnaise.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61442-hellmanns-celebrate-centennial-celebrity-chef-mario-batali-joining-america
At 90, Marjorie McFadden found herself unable to swallow. At Stanford Hospital & Clinics, she found innovative care that restored her ability to enjoy food again. Stanford digestive surgeon, Homero Rivas, MD, performed a per oral endoscopic myotomy, or POEM, to correct McFadden's achalasia, an unusual tightening of the muscles at the lower end of the esophagus. For McFadden's full story: http://stanfordhospital.org/newsEvents/newsletters/healthnotes/poem.html
In a revolutionary treatment for early-onset scoliosis (EOS), a team of surgeons implanted adjustable growing rods in two children from California. The pioneering surgeries — the first ever in the United States — were performed on May 7th at Rady Children’s Hospital in San Diego. The Food and Drug Administration (FDA) granted Compassionate Use approval to use the MAGEC™ (MAGnetic Expansion Control) System, developed by Ellipse Technologies, Inc., for these two patients.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61604-rady-children-s-hospital-san-diego-ellipse-magec-early-onset-scoliosis-eos
In recognition of Melanoma Monday® and National Melanoma/Skin Cancer Detection & Prevention MonthTM, MELA Sciences, Inc. (NASDAQ: MELA) visited the NASDAQ MarketSite in Times Square today to ring the Opening Bell and sponsor free skin cancer checks.
One American dies every hour from melanoma, the most deadly skin cancer. MELA Sciences, Inc. is the pioneer company behind MelaFind®, the first and only FDA-approved diagnostic tool that helps dermatologists detect melanoma at its most curable stage. MelaFind® was approved by the U.S. Food & Drug Administration (FDA) in Fall 2011, and since then has strategically rolled out the technology to dermatology practices across the country.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61584-mela-sciences-rings-opening-bell-awareness-melanoma-detection-prevention
Raptor Pharmaceutical Corp. (“Raptor” or the “Company”) (Nasdaq: RPTP), today announced that the U.S. Food and Drug Administration (FDA) has approved PROCYSBI™ (cysteamine bitartrate) delayed release capsules for the treatment of nephropathic cystinosis in adults and children 6 years and older. In a Phase 3 study, PROCYSBI showed consistent cystine depletion over the full 12-hour dosing period. Sustained levels of cysteamine have not historically been achieved in the majority of patients in this population. Studies have shown that sustained cystine depletion in patients may significantly delay disease progression, including kidney dysfunction, dialysis, kidney transplant, organ failure and premature death.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61338-raptor-pharmaceutical-procysbi-fda-approval-nephropathic-cystinosis
Today, Bayer HealthCare LLC, the makers of One A Day® Women’s Multivitamins, along with Feeding America®, the nation’s leading domestic hunger-relief charity, and nine-time Grammy Award winner Sheryl Crow kick off year two of their Nutrition Mission with the announcement of a donation program and grant opportunity to benefit Feeding America’s network of more than 200 community food banks that help distribute over 3 billion pounds of food to Americans annually.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61524-sheryl-crow-and-one-a-day-women-s-nutrition-mission-with-feeding-america
Any chef will tell you the choices you make in the grocery store can impact the quality of your output in the kitchen. According to TV chef personality and cookbook author Aida Mollenkamp, the first step to becoming a great home chef is to first be a responsible one – and that means knowing where your food comes from.
“You wouldn’t drive a car without the keys, so you shouldn’t cook without first having keys to the kitchen,” says Mollenkamp, author of the acclaimed cookbook Keys To The Kitchen (Chronicle Books, 2012).
To view Multimedia News Release, go to http://www.multivu.com/mnr/60898-food-network-aida-mollenkamp-recipes-tips-food-sourcing-cooking-channel
